Template:Metoprolol: Difference between revisions

Metoprolol
Lopressor® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Toprol XL® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Metoprolol
ClinicalTrials.gov

@@ Line 2: / Line 2: @@
 ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Metoprolol|{{fontcolor|#6C7B8B|Metoprolol}}]]'''''
 |-
-! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[Lopressor|Lopressor FDA Package Insert]]
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[Lopressor|Lopressor<sup>®</sup> FDA Package Insert]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol indications and usage|Indications and Usage]]
@@ Line 32: / Line 32: @@
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol labels and packages|Labels and Packages]]
 |-
-! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | TOPROL XL<sup>®</sup> FDA Package Insert
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[Toprol XL|Toprol XL<sup>®</sup> FDA Package Insert]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Metoprolol succinate indications and usage|Indications and Usage]]

Revision as of 19:07, 12 March 2014